Surprisingly, glucose transporter GLUT1 and the enzyme HK-II which catalyzes the first committed step of glycolysis, were pronouncedly inhibited by HF treatment in a dose-dependent manner, revealing that the upstream events of glucose metabolism could be mediated by Akt/mTORC1 signaling upon HF treatment. The gene discussed is HK2; the disease is hydrops fetalis.